HIV-1 ASPARTYL PROTEINASE RADIOPEPTIDASE ASSAY
HIV-1 ASPARTYL PROTEINASE RADIOPEPTIDASE ASSAY
批准号:
3489658
负责人:
MARTHA KNIGHT
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 1994-04-30
中文摘要
为了帮助寻找对抗HIV-1病毒的有效药物,
引起艾滋病,一个方便的放射肽酶测定,建议用于
筛选这种负责传染性的酶的抑制剂。
HIV-1乙酰基蛋白酶是HIV-1的三种功能酶之一,
逆转录病毒,剪切翻译的gag-pol多肽(病毒基因产物)
感染细胞中的成熟病毒体。 抑制这种酶
阻止受感染病毒粒子的细胞增殖。 一个敏感
该酶的生化测定设计为使用放射性标记的
底物,当被乙酰基蛋白酶切割时,
在溶液中容易计数的标记的肽片段。 我们提出
建立和优化检测方法,并开始筛选
抑制剂的
英文摘要
As an aid in the search for effective drugs against the HIV-1 virus that
causes AIDS, a convenient radiopeptidase assay is proposed to be used in
the screening for inhibitors of this enzyme responsible for infectivity.
The HIV-1 aspartyl proteinase, one of the 3 functional enzymes of the
retrovirus, clips the translated gag-pol polypeptide (viral gene product)
into the mature virions in the infected cell. Inhibition of this enzyme
prevents the cellular multiplication of infected virions. A sensitive
biochemical assay for this enzyme is designed using a radiolabeled
substrate that when cleaved by the aspartyl proteinase generates a
labeled peptide fragment that is easily counted in solution. We propose
to establish and optimize the assay, as well as to start screening for
inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BOMBESIN ANTAGONISTS
-
批准号:3492918
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1992
-
负责人:MARTHA KNIGHT
-
依托单位:
CHOLECYSTOKININ ANTAGONIST
-
批准号:3637943
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1990
-
负责人:MARTHA KNIGHT
-
依托单位:
ENDOTHELIN ANTAGONIST
-
批准号:3501653
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1989
-
负责人:MARTHA KNIGHT
-
依托单位:
CROSS-AXIS COIL PLANET CENTRIFUGE CHROMATOGRAPH
-
批准号:3498155
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1988
-
负责人:MARTHA KNIGHT
-
依托单位:
BOMBESIN ANALOGUES
-
批准号:3491714
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1986
-
负责人:MARTHA KNIGHT
-
依托单位:
CHOLECYSTOKININ ANALOGUES
-
批准号:3503996
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1985
-
负责人:MARTHA KNIGHT
-
依托单位:
海外基金